Infiltration with triamcinolone in patients with temporomandibular disorders

Objectives: TMJ (temporomandibular joint) Disorders produce pain affecting the quality of life for people who have it. The objective is to evaluate the effectiveness of infiltration with triamcinolone in patients with TMD (temporomandibular disorders) and facial pain, 1 month follow up.
Methods: not randomized 40 patients (6 men and 34 women) over 18 years with orofacial pain TMD, attending private practice, selected for convenience according to the inclusion criteria and uncontrolled clinical trial exclusion. The pain was measured by visual analog scale (VAS) before treatment and at the end. Each patient received infiltration three times, at the site of pain, with 1 mg Kenacort ® (triamcinolone) in 15-day interval. After 4 weeks post- treatment pain, adverse effects and satisfaction were evaluated.
Results: After 4 weeks post- treatment pain, adverse effects and satisfaction were evaluated. The initial pain intensity was 6,8 (2. A month later decreased to 1.8 (1.8, statistically significant P (0.00). Pain reduction was 78%.
Conclusions: La intensidad del dolor promedio inicial fue de 6.85, un mes después, disminuyó a 1,85; siendo una diferencia estadísticamente significativa. Se evidencia efectividad de la triamcinolona en el tratamiento del dolor de los TTM.
La infiltración con triamcinolona fue una opción de tratamiento para pacientes que presentaban TTM de tipo muscular, presentando seguridad y pocos efectos adversos.